Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Disease symbols : Lly save search
Roche granted FDA Breakthrough Device Designation for blood test to support earlier Alzheimer's disease diagnosis
Published: 2024-04-11 (Crawled : 05:00) - globenewswire.com
LLY | $728.765 -2.3% 1.5M
|
Health Technology
|
| O: 1.06%
H: 0.47%
C: -0.03%
fda device disease test granted blood designation for alzheimer's roche
Global Irritable Bowel Disease (IBD) Market Research Report 2024: Corticosteroids, JAK inhibitors, TNF inhibitors, Other Drug Classes Insights and Forecast 2019-2029
Published: 2024-03-13 (Crawled : 03:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -0.23%
H: 0.0%
C: 0.0%
NVS | $93.815 1.35% 410K
|
Health Technology
|
| O: -0.07%
H: 0.09%
C: -0.7%
JNJ | News | $146.39 0.45% 1.8M
|
Health Technology
|
| O: 0.66%
H: 0.0%
C: 0.0%
LLY | $728.765 -2.3% 1.5M
|
Health Technology
|
| O: 0.27%
H: 0.5%
C: 0.11%
ABBV | News | $166.43 1.08% 2M
|
Health Technology
|
| O: 0.59%
H: 0.01%
C: -1.45%
drug disease report research global market
Listeria Monocytogenes Infections Treatment Global Market Report 2024: Global Expansion in Listeria Monocytogenes Treatment Sector Predicted Amid Rising Foodborne Disease Incidence
Published: 2024-02-14 (Crawled : 00:00) - prnewswire.com
GLAXF | $20.2 510
|
Health Technology
|
| O: -2.14%
H: 0.0%
C: -0.63%
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: -2.71%
H: 0.0%
C: 0.0%
AZNCF | $138.24 800
|
Health Technology
|
| O: 0.87%
H: 0.21%
C: -2.23%
GSK | $39.605 0.85% 790K
|
Health Technology
|
| O: 0.89%
H: 0.41%
C: 0.1%
LLY | $728.765 -2.3% 1.5M
|
Health Technology
|
| O: 0.38%
H: 2.44%
C: 1.54%
VRTX | News | $395.42 0.49% 290K
|
Health Technology
|
| O: 0.56%
H: 0.49%
C: -0.12%
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: -1.1%
H: 0.0%
C: 0.0%
BIIB | $191.45 0.49% 310K
|
Health Technology
|
| O: 0.16%
H: 0.43%
C: -2.76%
AZN | $68.3 -0.09% 2M
|
Health Technology
|
| O: 0.28%
H: 0.93%
C: 0.75%
AMGN | $266.895 1.58% 950K
|
Health Technology
|
| O: -0.21%
H: 0.34%
C: 0.07%
disease report treatment expansion global infections market
Animal Therapeutics and Diagnostics Global Market Report 2024 - Dermatological Disease Management in Animals to Propel Market Growth
Published: 2024-02-13 (Crawled : 23:00) - prnewswire.com
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: -2.71%
H: 0.0%
C: 0.0%
ZTS | News | $147.61 -3.59% 2.5M
|
Health Technology
|
| O: 0.93%
H: 0.7%
C: -0.6%
TMO | News | $544.01 0.46% 470K
|
Health Technology
|
| O: 0.56%
H: 1.3%
C: 1.22%
QGEN | $40.015 1.38% 290K
|
Health Technology
|
| O: -1.14%
H: 1.3%
C: 1.2%
LLY | $728.765 -2.3% 1.5M
|
Health Technology
|
| O: 0.38%
H: 2.44%
C: 1.54%
ELAN | $13.005 -4.16% 1.8M
|
Process Industries
|
| O: 1.53%
H: 1.16%
C: 0.82%
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: -1.1%
H: 0.0%
C: 0.0%
QGEN | $40.03 1.42% 260K
|
Health Technology
|
| O: -1.14%
H: 1.3%
C: 1.2%
PAHC | $13.17 1.0% 13K
|
Health Technology
|
| O: 1.32%
H: 4.7%
C: 4.09%
NEOG P | $11.72 -1.76% 730K
|
Health Technology
|
| O: -0.24%
H: 4.39%
C: 3.29%
management propel disease report animal global animals dermatological diagnostics therapeutics growth market
Non-Alcoholic Fatty Liver Disease Market to Observe Impressive Growth by 2032, Evaluates DelveInsight | Key Companies - MediciNova, Eli Lilly and Company, AstraZeneca, Madrigal Pharmaceuticals, BioMarin Pharmaceutical, GlaxoSmithKline, Pfizer
Published: 2024-01-22 (Crawled : 22:00) - prnewswire.com
LLY | $728.765 -2.3% 1.5M
|
Health Technology
|
| O: -0.51%
H: 0.37%
C: 0.32%
MDGL | $214.99 -3.27% 170K
|
Health Technology
|
| O: 1.29%
H: 0.35%
C: -3.04%
HEPA | $2.1118 13K
|
Health Technology
|
| O: -0.48%
H: 7.69%
C: 1.44%
ALT | $6.78 -1.6% 1.4M
|
Commercial Services
|
| O: -0.8%
H: 6.02%
C: 0.6%
ALNY | News | $146.34 0.81% 64K
|
Health Technology
|
| O: 0.46%
H: 3.04%
C: 2.67%
ETNB | $8.83 -0.56% 130K
|
Health Technology
|
| O: 1.19%
H: 0.63%
C: -0.72%
liver disease companies key growth market
AC Immune’s Targeted Anti-pTau Active Immunotherapy for Alzheimer’s Disease Advances into Phase 2b Trial
Published: 2023-12-15 (Crawled : 12:30) - globenewswire.com
JNJ | News | $146.39 0.45% 1.8M
|
Health Technology
|
| O: -0.39%
H: 0.0%
C: 0.0%
LLY | $728.765 -2.3% 1.5M
|
Health Technology
|
| O: -4.44%
H: 0.0%
C: 0.0%
ACIU | $2.38 8.8K
|
Health Technology
|
| O: -1.62%
H: 9.04%
C: 7.4%
disease active alzheimer’s immunotherapy trial
Parkinson's Disease Therapeutics Market revenue to hit USD 12.32 Billion by 2033, Says We Market Research
Published: 2023-12-06 (Crawled : 15:30) - prnewswire.com
GLAXF | $20.2 510
|
Health Technology
|
| O: 1.64%
H: 0.0%
C: -1.33%
NVS | $93.815 1.35% 410K
|
Health Technology
|
| O: 0.52%
H: 0.18%
C: -0.43%
GSK | $39.605 0.85% 790K
|
Health Technology
|
| O: -0.03%
H: 0.28%
C: -0.41%
LLY | $728.765 -2.3% 1.5M
|
Health Technology
|
| O: 0.99%
H: 0.0%
C: 0.0%
ABBV | News | $166.43 1.08% 2M
|
Health Technology
|
| O: 0.26%
H: 0.0%
C: 0.0%
DNLI | $16.1 -3.01% 280K
|
Health Technology
|
| O: 0.05%
H: 5.74%
C: 3.18%
BIIB | $191.45 0.49% 310K
|
Health Technology
|
| O: 0.42%
H: 2.37%
C: 1.45%
disease parkinson's revenue research therapeutics market
AC Immune to Host KOL Webinar on Amyloid Plaque PET Imaging in Alzheimer’s Disease as a Surrogate of Clinical Efficacy on November 9, 2023
Published: 2023-11-02 (Crawled : 11:00) - globenewswire.com
LLY | $728.765 -2.3% 1.5M
|
Health Technology
|
| O: 4.42%
H: 0.0%
C: 0.0%
ACIU | $2.38 8.8K
|
Health Technology
|
| O: -1.38%
H: 0.0%
C: 0.0%
disease alzheimer’s imaging
Beam Announces Agreement for Lilly to Acquire Beam’s Opt-In Rights to Verve Therapeutics’ Base Editing Programs for Cardiovascular Disease
Published: 2023-10-31 (Crawled : 10:00) - globenewswire.com
LLY | $728.765 -2.3% 1.5M
|
Health Technology
|
| O: -0.03%
H: 0.0%
C: 0.0%
BEAM | $24.42 0.45% 440K
|
Health Technology
|
| O: 7.69%
H: 7.3%
C: 2.72%
disease acquire cardiovascular agreement
Redwire Announces First Spaceflight Mission for New Cutting-Edge Pharmaceutical Drug Development Lab, Partnering with Eli Lilly and Company to Expand Space Research to Study Heart Disease and Diabetes
Published: 2023-10-30 (Crawled : 13:00) - biospace.com/
LLY | $728.765 -2.3% 1.5M
|
Health Technology
|
| O: 0.69%
H: 0.0%
C: 0.0%
drug disease company space research heart diabetes study
AC Immune Clinical Data Published in Nature Communications Show Alpha-Synuclein PET Tracer ACI-12589 Has Potential as Neurodegenerative Disease Diagnostic
Published: 2023-10-27 (Crawled : 11:00) - globenewswire.com
LLY | $728.765 -2.3% 1.5M
|
Health Technology
|
| O: -2.09%
H: 0.0%
C: 0.0%
ACIU | $2.38 8.8K
|
Health Technology
|
| O: -10.03%
H: 0.0%
C: 0.0%
aci-1258 aci-12589 disease alpha-synuclein diagnostic communications neurodegenerative potential show
Lilly's Mirikizumab Helped Patients with Crohn's Disease Achieve Long-Term Remission in Phase 3 Trial
Published: 2023-10-12 (Crawled : 13:00) - biospace.com/
LLY | $728.765 -2.3% 1.5M
|
Health Technology
|
| O: 0.54%
H: 0.0%
C: 0.0%
disease trial
US FDA approves Jardiance® for the treatment of adults with chronic kidney disease
Published: 2023-09-22 (Crawled : 15:00) - biospace.com/
LLY | $728.765 -2.3% 1.5M
|
Health Technology
|
| O: -2.93%
H: 1.22%
C: 0.32%
jardiance fda disease kidney treatment
Conquering Challenges in the Solid Tumor Market: Your Guide to FDA-EMA Indications, Regulatory Compliance, and Market Access Excellence | Disease Landscape Insights
Published: 2023-09-21 (Crawled : 15:30) - prnewswire.com
AZNCF | $138.24 800
|
Health Technology
|
| O: -1.13%
H: 0.0%
C: -0.63%
JNJ | News | $146.39 0.45% 1.8M
|
Health Technology
|
| O: 0.52%
H: 0.57%
C: -0.56%
GSK | $39.605 0.85% 790K
|
Health Technology
|
| O: -0.5%
H: 0.26%
C: -0.69%
LLY | $728.765 -2.3% 1.5M
|
Health Technology
|
| O: -1.47%
H: 0.0%
C: 0.0%
BMY | $48.58 0.58% 2.6M
|
Health Technology
|
| O: -0.37%
H: 1.54%
C: 0.89%
ABBV | News | $166.43 1.08% 2M
|
Health Technology
|
| O: -0.04%
H: 0.76%
C: -0.16%
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: -1.16%
H: 0.0%
C: 0.0%
AZN | $68.3 -0.09% 2M
|
Health Technology
|
| O: 0.19%
H: 0.03%
C: -1.57%
AMGN | $266.895 1.58% 950K
|
Health Technology
|
| O: 0.22%
H: 0.15%
C: -0.98%
disease tumor market
Reshaping Oncology Research and Consulting services: How DLI Empowers Every Step of the Journey | Disease Landscape Insights
Published: 2023-09-21 (Crawled : 08:00) - prnewswire.com
LLY | $728.765 -2.3% 1.5M
|
Health Technology
|
| O: -1.47%
H: 0.0%
C: 0.0%
disease research
Insights Into the Global Alzheimer's Disease Market, 2023-2032 - Eli Lilly's Donanemab Poised as Front-Runner for 2024 Market Debut, Set to Rival Biogen and Eisai's LEQEMBI in Emerging Therapy Arena
Published: 2023-08-18 (Crawled : 19:00) - prnewswire.com
LLY | $728.765 -2.3% 1.5M
|
Health Technology
| Email alert
Add to watchlist
leqembi disease global alzheimer's set therapy market
Jardiance® (empagliflozin) approved in the EU for the treatment of adults with chronic kidney disease
Published: 2023-07-25 (Crawled : 13:00) - biospace.com/
LLY | $728.765 -2.3% 1.5M
|
Health Technology
|
| O: -0.34%
H: 0.69%
C: -0.05%
jardiance disease kidney approved treatment
Allen Institute for Immunology partners with Lilly to better understand autoimmune disease
Published: 2023-07-18 (Crawled : 18:00) - biospace.com/
LLY | $728.765 -2.3% 1.5M
|
Health Technology
|
| O: -0.04%
H: 1.43%
C: 0.95%
institute disease immunology
Lilly Announces Webcast to Provide Alzheimer's Disease Update at AAIC
Published: 2023-07-11 (Crawled : 18:00) - biospace.com/
LLY | $728.765 -2.3% 1.5M
|
Health Technology
|
| O: -0.7%
H: 0.12%
C: -2.36%
disease update alzheimer's aaic
Chronic Kidney Disease - Market Insight, Epidemiology and Market Forecast 2023-2032: With Focus on United States, EU4 (Germany, Spain, Italy, and France), the United Kingdom, and Japan
Published: 2023-06-28 (Crawled : 02:00) - prnewswire.com
NVO | $123.01 0.21% 2.6M
|
Health Technology
|
| O: 1.47%
H: 0.0%
C: -0.94%
LLY | $728.765 -2.3% 1.5M
|
Health Technology
|
| O: 0.86%
H: 0.0%
C: -2.09%
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: 0.75%
H: 0.0%
C: 0.0%
RETA | $172.36 0.02% 0.03% 0
|
Health Technology
|
| O: 6.1%
H: 5.34%
C: 0.82%
disease japan kidney market
Gainers vs Losers
| 77% | 23% |
Top 10 Gainers
AGBA | News | $1.22 205.0% 86M
|
Finance
EGOX | $0.054 50.0% 290M
|
CHRO | $1.66 35.51% 70K
|
n/a
INDO | $5.43 33.09% 10M
|
Energy Minerals
NVFY | $2.71 28.44% 31M
|
Consumer Durables
ZCMD | $1.86 28.28% 29M
|
Commercial Services
RWOD | $10.08 26.05% 5.6M
|
n/a
HUSA 4 | $2.07 23.95% 2.1M
|
Energy Minerals
TPET | $0.4001 22.02% 35M
|
n/a
SRFM 4 | $0.6 21.29% 850K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.